Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2862 (LINC02862) is a member of the lincRNA class, which is defined by being a long (>200 nucleotides), autonomously transcribed RNA that does not overlap with annotated protein-coding genes[1][3]. While its specific function is not currently described in the literature, lincRNAs in general are known to regulate gene expression by interacting with chromatin, acting as scaffolds for proteins, and influencing RNA stability or transcriptional activity[3]. There is no evidence that LINC02862 is a direct therapeutic target or has well-described disease associations, drug interactions, or use as a biomarker at this time[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2862 (LINC02862).